Compare AAT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAT | PRGO |
|---|---|---|
| Founded | 1967 | 1887 |
| Country | United States | Ireland |
| Employees | 208 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2010 | 2013 |
| Metric | AAT | PRGO |
|---|---|---|
| Price | $22.77 | $13.04 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $19.50 | $19.33 |
| AVG Volume (30 Days) | 388.5K | ★ 3.0M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | 6.65% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $436,204,000.00 | $800,000.00 |
| Revenue This Year | $4.33 | N/A |
| Revenue Next Year | $0.22 | $1.02 |
| P/E Ratio | $287.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.72 | $9.23 |
| 52 Week High | $25.97 | $24.61 |
| Indicator | AAT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 65.56 |
| Support Level | $18.23 | $12.45 |
| Resistance Level | $25.76 | $13.89 |
| Average True Range (ATR) | 0.52 | 0.51 |
| MACD | -0.10 | 0.19 |
| Stochastic Oscillator | 23.43 | 76.99 |
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.